436 related articles for article (PubMed ID: 19166685)
1. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction.
Chia S; Nagurney JT; Brown DF; Raffel OC; Bamberg F; Senatore F; Wackers FJ; Jang IK
Am J Cardiol; 2009 Feb; 103(3):333-7. PubMed ID: 19166685
[TBL] [Abstract][Full Text] [Related]
2. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of postprocedural leukocyte count on myocardial perfusion, left ventricular function and clinical outcomes in ST-elevated myocardial infarction after percutaneous coronary intervention.
He R; Li HY; Guo LJ; Zhang FC; Niu J; Zhang YZ; Wang GS; Yang ZH; Gao W
Chin Med J (Engl); 2012 Mar; 125(6):1023-9. PubMed ID: 22613525
[TBL] [Abstract][Full Text] [Related]
6. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.
Sciagrà R; Parodi G; Migliorini A; Valenti R; Antoniucci D; Sotgia B; Pupi A
Am J Cardiol; 2006 Jan; 97(1):48-54. PubMed ID: 16377283
[TBL] [Abstract][Full Text] [Related]
7. [Increased postprocedural neutrophil count is an independent predictive factor of poor prognosis in acute ST elevation myocardial infarction patients treated with percutaneous coronary intervention].
He R; Yang ZH; Li HY; Guo LJ; Zhang FC; Niu J; Zhang YZ; Wang GS; Gao W
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):44-8. PubMed ID: 19671351
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Park JJ; Jang HJ; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Cho GY; Chae IH; Choi DJ
Am J Cardiol; 2013 Mar; 111(5):636-42. PubMed ID: 23273716
[TBL] [Abstract][Full Text] [Related]
9. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.
Stone GW; Webb J; Cox DA; Brodie BR; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Dulas D; Rutherford BD; Antoniucci D; Krucoff MW; Gibbons RJ; Jones D; Lansky AJ; Mehran R;
JAMA; 2005 Mar; 293(9):1063-72. PubMed ID: 15741528
[TBL] [Abstract][Full Text] [Related]
10. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
[TBL] [Abstract][Full Text] [Related]
11. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
[TBL] [Abstract][Full Text] [Related]
12. Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction.
Kirtane AJ; Bui A; Murphy SA; Barron HV; Gibson CM
Am J Cardiol; 2004 Mar; 93(5):532-6. PubMed ID: 14996574
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty.
Tzivoni D; Koukoui D; Guetta V; Novack L; Cowing G;
Am J Cardiol; 2008 Mar; 101(6):753-7. PubMed ID: 18328834
[TBL] [Abstract][Full Text] [Related]
15. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
[TBL] [Abstract][Full Text] [Related]
16. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Hahn JY; Kim HJ; Choi YJ; Jo SH; Kim HJ; Lee S; Ahn KJ; Song YB; Choi JH; Choi SH; Choi YJ; Lee KH; Lee SH; Gwon HC
Am Heart J; 2011 Dec; 162(6):1026-33. PubMed ID: 22137076
[TBL] [Abstract][Full Text] [Related]
18. Effect of caldaret on the incidence of severe left ventricular dysfunction in patients with ST-elevation myocardial infarction undergoing primary coronary intervention.
Tzivoni D; Balkin J; Bär FW; Hibberd M; Reiber JH; Cowing G
Am J Cardiol; 2009 Jan; 103(1):1-4. PubMed ID: 19101220
[TBL] [Abstract][Full Text] [Related]
19. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size.
Nijveldt R; van der Vleuten PA; Hirsch A; Beek AM; Tio RA; Tijssen JG; Piek JJ; van Rossum AC; Zijlstra F
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1187-94. PubMed ID: 19833308
[TBL] [Abstract][Full Text] [Related]
20. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.
Pride YB; Giuseffi JL; Mohanavelu S; Harrigan CJ; Manning WJ; Gibson CM; Appelbaum E
Am J Cardiol; 2010 Sep; 106(5):635-40. PubMed ID: 20723637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
